Anixa Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIX and other ETFs, options, and stocks.About ANIX
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other.
CEOAmit D. Kumar
CEOAmit D. Kumar
Employees5
Employees5
HeadquartersSan Jose, California
HeadquartersSan Jose, California
Founded1982
Founded1982
Employees5
Employees5
ANIX Key Statistics
Market cap102.04M
Market cap102.04M
Price-Earnings ratio-9.05
Price-Earnings ratio-9.05
Dividend yield—
Dividend yield—
Average volume260.93K
Average volume260.93K
High today$3.24
High today$3.24
Low today$3.06
Low today$3.06
Open price$3.11
Open price$3.11
Volume184.82K
Volume184.82K
52 Week high$5.46
52 Week high$5.46
52 Week low$2.07
52 Week low$2.07
Stock Snapshot
With a market cap of 102.04M, Anixa Biosciences(ANIX) trades at $3.12. The stock has a price-to-earnings ratio of -9.05.
As of 2025-12-31, Anixa Biosciences(ANIX) stock has fluctuated between $3.06 and $3.24. The current price stands at $3.12, placing the stock +2.0% above today's low and -3.7% off the high.
The Anixa Biosciences(ANIX)'s current trading volume is 184.82K, compared to an average daily volume of 260.93K.
In the last year, Anixa Biosciences(ANIX) shares hit a 52-week high of $5.46 and a 52-week low of $2.07.
In the last year, Anixa Biosciences(ANIX) shares hit a 52-week high of $5.46 and a 52-week low of $2.07.
People also own
Based on the portfolios of people who own ANIX. This list is generated using Robinhood data, and it’s not a recommendation.